JANUARY/FEBRUARY 2016 | Carolyn D. Runowicz, MD; Corinne R. Leach, PhD, MS, MPH; N. Lynn Henry, MD, PhD; Karen S. Henry, MSN, ARNP, FNP-BC, AOCNP; Rebecca L. Cowens-Alvarado, MPH; Rachel S. Cannady, BS; Mandi L. Pratt-Chapman, MA; Stephen B. Edge, MD, FACS; Linda A. Jacobs, PhD, RN; Arti Hurria, MD; Lawrence B. Marks, MD; Samuel J. LaMonte, MD; Ellen Warner, MD, FRCPC, FACP, MSC; Gary H. Lyman, MD, MPH, FASCO, FACP; Patricia A. Ganz, MD
The American Cancer Society (ACS) and the American Society of Clinical Oncology (ASCO) have jointly published a guideline for breast cancer survivorship care. The guideline aims to provide recommendations to assist primary care and other clinicians in managing the long-term and late effects of breast cancer treatment on female adult survivors. The guideline is based on a systematic review of the literature and expert consensus. Key areas covered include surveillance for breast cancer recurrence, screening for second primary cancers, assessment and management of physical and psychosocial long-term and late effects, health promotion, and care coordination. Recommendations are provided for each area, with a focus on individualizing follow-up care based on patient risk factors and preferences. The guideline emphasizes the importance of regular history and physical examinations, genetic counseling, and addressing specific concerns such as body image and lymphedema. The guideline is intended to improve the quality of clinical follow-up care for breast cancer survivors and enhance their overall health and quality of life.The American Cancer Society (ACS) and the American Society of Clinical Oncology (ASCO) have jointly published a guideline for breast cancer survivorship care. The guideline aims to provide recommendations to assist primary care and other clinicians in managing the long-term and late effects of breast cancer treatment on female adult survivors. The guideline is based on a systematic review of the literature and expert consensus. Key areas covered include surveillance for breast cancer recurrence, screening for second primary cancers, assessment and management of physical and psychosocial long-term and late effects, health promotion, and care coordination. Recommendations are provided for each area, with a focus on individualizing follow-up care based on patient risk factors and preferences. The guideline emphasizes the importance of regular history and physical examinations, genetic counseling, and addressing specific concerns such as body image and lymphedema. The guideline is intended to improve the quality of clinical follow-up care for breast cancer survivors and enhance their overall health and quality of life.